Johnson Matthey (OTCMKTS:JMPLY) Rating Lowered to Hold at Zacks Research

Johnson Matthey (OTCMKTS:JMPLY) was downgraded by investment analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.

Other research analysts also recently issued reports about the stock. Citigroup reissued a “neutral” rating on shares of Johnson Matthey in a report on Tuesday, October 21st. Jefferies Financial Group raised Johnson Matthey to a “strong-buy” rating in a research note on Thursday, October 9th. One analyst has rated the stock with a Strong Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Johnson Matthey currently has an average rating of “Moderate Buy”.

Johnson Matthey Stock Up 0.6%

JMPLY stock opened at $55.95 on Thursday. The firm has a 50 day moving average of $54.59 and a 200-day moving average of $48.56. Johnson Matthey has a 12 month low of $29.01 and a 12 month high of $58.40. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.01 and a current ratio of 1.42.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.